La ligne téléphonique n’est pas disponible pour le moment.Pour toute demande veuillez envoyer un email a support@advfn.fr

Actualités Johnson & Johnson - JNJ

Les meilleurs offres pour accéder les cours en temps réel en illimité
Expert
Abonnement Mensuel
Seulement
92,39 €
Trader
Abonnement Mensuel
Seulement
34,09 €
Trade Alert US
Abonnement Mensuel
Seulement
52,79 €
Prix hors taxes
Nom Action Symbole Action Marché Type ISIN Description Action
Johnson & Johnson JNJ NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Haut Plus Bas Ouverture Clôture Veille Dernier échange
  1,43 1,02% 141,88 142,36 141,00 141,25 140,45 21:15:37
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/6/201921:57PRNUSJohnson & Johnson to Host Investor Conference Call on..
14/6/201914:36DJNJanssen Says Guselkumab Psoriatic Arthritis Studies Meet..
12/6/201923:11EDGARStatement of Changes in Beneficial Ownership (4)
12/6/201921:49DJNJ&J, Colgate-Palmolive Ordered to Pay Nearly $10 Million in..
11/6/201923:03EDGARStatement of Changes in Beneficial Ownership (4)
11/6/201919:36DJNGenmab, Janssen in Cancer-Drug Licensing Deal
11/6/201917:41DJNGenmab, J&J's Janssen in Pact for HexaBody-CD38 License
05/6/201915:39PRNUSJohnson & Johnson Releases 2018 Health for Humanity Report
03/6/201917:31DJNJNJ's Janssen Long-Term Data Show Imbruvica Sustained..
03/6/201915:30PRNUSMyPhillyLawyer Helps Secure $80 Million Victory for..
01/6/201909:02DJNJ&J Is Hit With $300 Million Jury Award in Talc Case -- WSJ
01/6/201900:15DJNJohnson & Johnson Hit With $300 Million in Punitive Damages..
31/5/201919:40DJNJury Orders Johnson & Johnson to Pay $300 Million Punitive..
30/5/201900:20DJNJanssen Pharma: Darzalex Combo Therapy Increases..
29/5/201920:53EDGARSpecialized Disclosure Report (sd)
29/5/201920:30DJNJohnson & Johnson Weighs on Pharmaceutical ETFs
29/5/201900:24DJNJohnson & Johnson, Oklahoma Spar in Opioid Trial
28/5/201918:23DJNOpioid Suits May Reduce Appetite for Pharma Companies -- ESG..
27/5/201914:29DJNFirst Big Trial in Opioid Crisis Set to Kick Off in Oklahoma
22/5/201915:51DJNJ&J Unit Gets FDA Priority Review of Invokana in Chronic..
21/5/201920:14DJFRTalc à l'amiante: J&J lourdement condamné, prévoit de faire..
21/5/201919:56DJNUpdate: N.Y. Jury Delivers $25 Million Judgment Against..
21/5/201919:52DJNCorrection to Johnson & Johnson Jury Story
21/5/201919:41DJNN.Y. Jury Delivers $25 Million Judgment Against Johnson &..
17/5/201914:52PRNUSJohnson & Johnson to Participate in Bernstein's 35th Annual..
15/5/201917:58DJFRJ&J veut lancer 10 "blockbusters" dans les prochaines années
15/5/201912:40PRNUSJohnson & Johnson Outlines Strategy to Deliver Above-Market..
09/5/201909:02DJNTakeda Sells Eye Drug to Novartis -- WSJ
08/5/201916:24DJNProtagonist Shares Up 17% After Expanded Janssen Agreement
07/5/201918:21DJFRJ&J va payer 1 milliard de dollars pour solder des..
07/5/201912:40JCNENAnnouncing the 2019 Tangrams Strategy & Effectiveness Awards..
01/5/201922:47EDGARQuarterly Report (10-q)
26/4/201923:13EDGARInitial Statement of Beneficial Ownership (3)
26/4/201923:00EDGARCurrent Report Filing (8-k)
25/4/201917:36DJFRJohnson & Johnson relève son dividende de 5,6%
25/4/201917:28DJNJohnson & Johnson Raises Quarterly Dividend by 5.6% to 95..
25/4/201917:19DJNJohnson & Johnson Raises Quarterly Dividend by 5.6% to 95..
25/4/201916:40PRNUSJohnson & Johnson Announces Dividend Increase of 5.6%
25/4/201900:44PRNUSJohnson & Johnson to Host Pharmaceutical Business Review
23/4/201914:42DJNBausch Health, J&J Reach Deal On Litigation Over Body Powder
22/4/201922:54DJFRKraft Heinz change de DG pour relancer ses marques
22/4/201921:43DJNWashington State AG: J&J to Pay $9.9 Million for Failing to..
18/4/201921:36DJNPfizer, Johnson & Johnson Weigh on Pharmaceutical ETFs
17/4/201909:02DJNHigher Drug Sales Aid J&J Results -- WSJ
16/4/201917:46DJNHigher Prescription-Drug Sales Aid Johnson & Johnson..
16/4/201917:27DJNCorrection to Johnson & Johnson Earnings Article
16/4/201913:53EDGARCurrent Report Filing (8-k)
16/4/201913:53DJNJohnson & Johnson Raises Full-Year Guidance
16/4/201913:48DJFRJohnson & Johnson bat le consensus au T1 et relève sa..
16/4/201912:40PRNUSJohnson & Johnson Reports 2019 First-Quarter Results:
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NYSE
JNJ
Johnson & ..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Conditions Générales

P: V: D:20190620 19:30:44